Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease. [electronic resource]
Producer: 20121119Description: 11820-34 p. digitalISSN:- 1529-2401
- Alzheimer Disease -- complications
- Aminophenols -- therapeutic use
- Amyloid Precursor Protein Secretases -- genetics
- Amyloid beta-Peptides -- metabolism
- Amyloid beta-Protein Precursor -- genetics
- Analysis of Variance
- Animals
- Brain -- cytology
- Caffeine -- pharmacology
- Calcium -- metabolism
- Calcium Channel Blockers -- therapeutic use
- Cells, Cultured
- Cytosol -- drug effects
- Dantrolene -- pharmacology
- Disease Models, Animal
- Embryo, Mammalian
- Endoplasmic Reticulum -- drug effects
- Enzyme Inhibitors -- therapeutic use
- Exploratory Behavior -- drug effects
- Gene Expression Regulation -- drug effects
- Humans
- Inositol 1,4,5-Trisphosphate Receptors -- genetics
- Maleimides -- therapeutic use
- Maze Learning -- drug effects
- Membrane Potentials -- drug effects
- Membrane Proteins -- metabolism
- Memory Disorders -- drug therapy
- Mice
- Mice, Transgenic
- Muscle Relaxants, Central -- pharmacology
- Mutation -- genetics
- Nerve Tissue Proteins -- metabolism
- Neuroblastoma -- pathology
- Neurons -- drug effects
- Patch-Clamp Techniques
- Peptide Fragments -- metabolism
- Phosphorylation -- drug effects
- Plaque, Amyloid -- metabolism
- Purines -- therapeutic use
- RNA, Messenger -- metabolism
- Reaction Time -- drug effects
- Recognition, Psychology -- drug effects
- Roscovitine
- Ryanodine Receptor Calcium Release Channel -- genetics
- Transfection
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.